Harfst & Associates, Inc. Abbott Laboratories Transaction History

Harfst & Associates, Inc.

$444 Million
Q3 2024

A detailed history of Harfst & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Harfst & Associates, Inc. holds 19,112 shares of ABT stock, worth $2.18 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

19,112

Previous 19,217 0.55%

Holding current value

$2.18 Million

Previous $2 Million 9.12%

% of portfolio

0.49%

Previous 0.47%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $10,507 - $12,403	-105 Reduced 0.55%	19,112 $2.18 Million
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $42,709 - $47,674	424 Added 2.26%	19,217 $2 Million
Q1 2024 Aug 01, 2024	BUY	$109.52 - $120.96 $2.06 Million - $2.27 Million	18,793 New	18,793 $2.14 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $28,680 - $35,107	-318 Reduced 1.84%	16,931 $1.86 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $7,355 - $8,825	77 Added 0.45%	17,249 $1.67 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $99,469 - $110,830	987 Added 6.1%	17,172 $1.87 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $290 - $342	-3 Reduced 0.02%	16,185 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $20,057 - $23,530	211 Added 1.32%	16,188 $1.78 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $261,639 - $302,929	2,704 Added 20.37%	15,977 $1.55 Million
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $245,274 - $296,458	2,403 Added 22.11%	13,273 $1.44 Million
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $64,535 - $78,696	566 Added 5.49%	10,870 $1.29 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $51,757 - $63,374	448 Added 4.55%	10,304 $1.45 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $11,199 - $12,389	96 Added 0.98%	9,856 $1.16 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $68,975 - $81,193	652 Added 7.16%	9,760 $1.13 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $48,216 - $56,805	443 Added 5.11%	9,108 $1.09 Million
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $4,410 - $4,805	-42 Reduced 0.48%	8,665 $948,000
Q3 2020 Nov 04, 2020	BUY	$91.64 - $111.29 $592,086 - $719,044	6,461 Added 287.67%	8,707 $947,000
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $171,976 - $220,108	2,246 New	2,246 $205,000
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $145,114 - $212,196	-2,310 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $181,358 - $201,894	2,310 New	2,310 $200,000
Q3 2017 Nov 07, 2017	SELL	$48.06 - $53.64 $112,508 - $125,571	-2,341 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	2,341	2,341 $113,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.

Account

Harfst & Associates, Inc. Abbott Laboratories Transaction History